FDA Approps Bill Debate Could Include “Controversial Amendments,” Sen. Hatch Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Amendments on drug importation, Plan B and follow-on biologics could be brought to the Senate floor during debate on the Agriculture appropriations measure.
You may also be interested in...
Plan B Language To Be Included In Conference Report On FDA Appropriations
Sen. Murray withdrew four amendments to the Ag Approps bill in exchange for a pledge that language will appear in the report expressing bipartisan concern over the emergency contraceptive’s review process.
Plan B Language To Be Included In Conference Report On FDA Appropriations
Sen. Murray withdrew four amendments to the Ag Approps bill in exchange for a pledge that language will appear in the report expressing bipartisan concern over the emergency contraceptive’s review process.
Sandoz Sues FDA For Inaction On Omnitrope NDA
Lawsuit seeks a court declaration that the 505(b)(2) pathway “can be used for protein-based biologic drugs regulated under Section 505 of the FD&C Act.”